BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16273189)

  • 1. Biomarker analysis in carcinoma ex pleomorphic adenoma at an early phase of carcinomatous transformation.
    Freitas LL; Araújo VC; Martins MT; Chone C; Crespo A; Altemani A
    Int J Surg Pathol; 2005 Oct; 13(4):337-42. PubMed ID: 16273189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas.
    DeRoche TC; Hoschar AP; Hunt JL
    Arch Pathol Lab Med; 2008 Dec; 132(12):1907-11. PubMed ID: 19061288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
    J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
    Furuse C; Miguita L; Rosa AC; Soares AB; Martinez EF; Altemani A; de Araújo VC
    J Oral Pathol Med; 2010 Aug; 39(7):540-7. PubMed ID: 20149060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
    Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
    Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Grade Carcinoma Ex-Pleomorphic Adenoma: Diagnosis and Diagnostic Challenges Caused by Fine Needle Aspiration: Report of Three Cases and Review of Literature.
    Covinsky M; Cai Z; Ambelil M; Liu J; Zhu H
    Head Neck Pathol; 2018 Mar; 12(1):82-88. PubMed ID: 28589437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
    Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
    Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
    de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
    Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
    Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
    J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
    Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
    Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry.
    Di Palma S; Skálová A; Vanìèek T; Simpson RH; Stárek I; Leivo I
    Histopathology; 2005 Feb; 46(2):144-52. PubMed ID: 15693886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
    de Souza AA; Altemani A; Passador-Santos F; Turssi CP; de Araujo NS; de Araújo VC; Soares AB
    Virchows Arch; 2015 Sep; 467(3):295-301. PubMed ID: 26155914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma ex pleomorphic adenoma of the salivary glands: distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation.
    Kim JW; Kwon GY; Roh JL; Choi SH; Nam SY; Kim SY; Cho KJ
    J Korean Med Sci; 2011 Oct; 26(10):1277-85. PubMed ID: 22022178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell carcinoma arising in a pleomorphic adenoma of the submandibular gland.
    Cassidy M; Connolly CE
    J Laryngol Otol; 1994 Jun; 108(6):529-32. PubMed ID: 7517988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
    Katori H; Nozawa A; Tsukuda M
    Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.
    Patel RS; Hughes CW; Fredericks S; Lee CS; Rose B; Gao K; Smith G; Hong A; O'Brien CJ
    Histopathology; 2007 Jul; 51(1):21-5. PubMed ID: 17593077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.